Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades

被引：7
|
作者：
Eskola, Vesa [1 ]
Pohjankoski, Heini [2 ]
Kroeger, Liisa [3 ]
Aalto, Kristiina [4 ]
Latva, Katariina [2 ]
Korppi, Matti [1 ,5 ]
机构：
[1] Tampere Univ Hosp, Dept Pediat, POB 2000, FIN-33521 Tampere, Finland
[2] Pajjat Hame Dist Cent Hosp, Dept Pediat, Lahti, Finland
[3] Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland
[4] Helsinki Univ Hosp, Dept Pediat, Helsinki, Finland
[5] Univ Tampere, Pediat Res Ctr, Tampere, Finland
来源：
ACTA PAEDIATRICA | 2018年 / 107卷 / 04期
关键词：
Biologics; Children; Cryopyrin-associated periodic syndrome; Interleukin-1; Periodic fever; SUSTAINED RESPONSE; OPEN-LABEL; CANAKINUMAB; EFFICACY; SAFETY; MANAGEMENT; RILONACEPT; PHENOTYPE; ANAKINRA; LIFE;
D O I：
10.1111/apa.14217
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Cryopyrin-associated periodic syndrome (CAPS) is caused by a mutation in the NLRP3 gene encoding cryopyrin production. Overproduction of interleukin-1 (IL-1) leads to symptoms that are associated with elevated inflammatory markers, including periodic fever and a rash. We provide a clinical overview of CAPS in children, including three Finnish case studies. Conclusion: When CAPS has been diagnosed, an IL-1 blockade with biological should be introduced to lessen the symptoms and to prevent the progression of organ damage.
引用
收藏
页码：577 / 580
页数：4
相关论文
共 50 条
  • [41] Cryopyrin-associated periodic syndrome with inflammatory bowel disease: A case study
    Raymond, Karen N.
    Martin, Jonathan E. D.
    JGH OPEN, 2021, 5 (05): : 629 - 631
  • [42] Obvious optic disc swelling in a patient with cryopyrin-associated periodic syndrome
    Kawai, Mariko
    Yoshikawa, Tadanobu
    Nishikomori, Ryuta
    Heike, Toshio
    Takahashi, Kanji
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1581 - 1584
  • [43] Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS)
    Haverkamp, M. H.
    van de Vosse, E.
    Goldbach-Mansky, R.
    Holland, S. M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 177 (03) : 720 - 731
  • [44] Cryopyrin-associated Periodic Syndrome: A Case Report and Review of the Japanese Literature
    Aoyama, Kumi
    Amano, Hiroo
    Takaoka, Yuki
    Nishikomori, Ryuta
    Ishikawa, Osamu
    ACTA DERMATO-VENEREOLOGICA, 2012, 92 (04) : 395 - 398
  • [45] Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
    Toker, Ori
    Hashkes, Philip J.
    BIOLOGICS-TARGETS & THERAPY, 2010, 4 : 131 - 138
  • [46] A case of cryopyrin-associated periodic fever syndrome during canakinumab administration complicated by inflammatory bowel disease
    Yamasaki, Yuichi
    Kubota, Tomohiro
    Takei, Syuji
    Imanaka, Hiroyuki
    Nonaka, Yukiko
    Kawano, Yoshifumi
    CLINICAL RHEUMATOLOGY, 2021, 40 (01) : 393 - 397
  • [47] Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome
    Ait-Abdesselam, Tassadit
    Lequerre, Thierry
    Legallicier, Bruno
    Francois, Arnaud
    Loet, Xavier Le
    Vittecoq, Olivier
    JOINT BONE SPINE, 2010, 77 (06) : 616 - 617
  • [48] Inhibition of the NF-κB pathway as a candidate therapeutic strategy for cryopyrin-associated periodic syndrome
    Shimogaki, Satoka
    Ito, Sayaka
    Komatsu, Sachiyo
    Koike, Ryuji
    Miyasaka, Nobuyuki
    Umezawa, Kazuo
    Kubota, Tetsuo
    MODERN RHEUMATOLOGY, 2014, 24 (03) : 517 - 524
  • [49] Rapid and Sustained Long-Term Efficacy and Safety of Canakinumab in Patients With Cryopyrin-Associated Periodic Syndrome Ages Five Years and Younger
    Brogan, Paul A.
    Hofer, Michael
    Kuemmerle-Deschner, Jasmin B.
    Kone-Paut, Isabelle
    Roesler, Joachim
    Kallinich, Tilmann
    Horneff, Gerd
    Calvo Penades, Inmaculada
    Sevilla-Perez, Belen
    Goffin, Laurence
    Lauwerys, Bernard R.
    Lachmann, Helen J.
    Uziel, Yosef
    Wei, Xiaoling
    Laxer, Ronald M.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (11) : 1955 - 1963
  • [50] Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study
    Kone-Paut, I.
    Quartier, P.
    Fain, O.
    Grateau, G.
    Pillet, P.
    Le Blay, P.
    Bonnet, F.
    Despert, V.
    Stankovic-Stojanovic, K.
    Willemin, L.
    Quere, S.
    Reigneau, O.
    Hachulla, E.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (06) : 903 - 911
12345